Contrast-free Virtually-enhanced MRI for Precise Tumour Treatment in Carcinoma
Principal Investigator:
Prof. Jing CAI, Associate Dean of Faculty of Health and Social Sciences, Professor of Department of Health Technology and Informatics, Advisor of MedVision Limited (a PolyU Startup)
This innovative system enables precise tumour delineation using contrast-free, virtually enhanced MRI data. It can:
• Avoid harmful contrast agents that cause discomfort and side effects for patients
• Obtain clear images of tumours comparable to conventional contrast-enhanced MRI
• Delineate tumours precisely for accurate diagnosis and personalised treatment
• Optimise treatment planning for precise targeting and reduced damage to healthy tissue
• Improve efficiency and save time with efficient and reliable systems
This innovation has profound implications for cancer diagnosis and treatment. It enhances patient safety, provides a non-invasive option, and improves the accuracy of tumour delineation. This translates into precise treatment planning, personalised care, and reduced patient risk. The streamlined workflow also improves resource utilisation and can reduce healthcare costs. Ultimately, it contributes to better patient outcomes, higher treatment success rates, and improved overall quality of cancer care.